Wuhan Hiteck Biological Overview
- Status
-
Public
- Employees
-
1,143
- Stock Symbol
-
300683
- Investments
-
1
- Share Price
-
$5.64
- (As of Monday Closing)
Wuhan Hiteck Biological General Information
Description
Wuhan Hiteck Biological Pharma Co Ltd is a biopharmaceutical manufacturing enterprise in China. The company is primarily engaged in the development, production and sale of biological products. Its product portfolio comprises rat nerve growth factor freeze-dried powder injection, injection of anti-hepatitis B transfer factor freeze-dried powder injection, thrombin and other chemicals. The company also has more than 20 kinds of products such as hepatitis B treatment drug op Heparin and hemostatic agent thrombin.
Contact Information
Primary Industry
Drug Discovery
Stock Exchange
SHE
Primary Office
- Hite Science and Technology Park
- Wuhan Economic Development Zone
- Wuhan, Hubei 430056
- China
+86 027 0000 0000
Wuhan Hiteck Biological Stock Performance
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $5.64 | $5.59 | $4.47 - $9.56 | $689M | 122M | 1.14M | $0.04 |
Wuhan Hiteck Biological Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 503,505 | 985,621 | 488,621 | 281,912 |
| Revenue | 117,312 | 95,195 | 75,865 | 89,753 |
| EBITDA | 2,675 | 7,010 | (4,164) | 12,198 |
| Net Income | 4,247 | 4,283 | (3,622) | 9,123 |
| Total Assets | 375,444 | 423,199 | 335,828 | 310,980 |
| Total Debt | 14,617 | 17,419 | 2,141 | 26,479 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Wuhan Hiteck Biological Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Wuhan Hiteck Biological Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Wuhan Hiteck Biological Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000 000000000 | 21-Jul-2021 | 00000 0000 | 00.000 | Drug Discovery |